These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21679595)

  • 1. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritoneal carcinomatosis.
    Matsuda K; Hotta T; Takifuji K; Kobayashi Y; Tsuji T; Nagai Y; Horiuchi T; Yamaue H
    Am Surg; 2011 May; 77(5):602-7. PubMed ID: 21679595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
    Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
    Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
    World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
    Berberoglu U
    Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
    Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
    Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL
    Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.
    Matsuda K; Hotta T; Takifuji K; Yamamoto M; Nasu T; Togo N; Oka M; Tabuse K; Yamaue H
    Surgery; 2012 Feb; 151(2):238-44. PubMed ID: 21176934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.
    Glehen O; Cotte E; Schreiber V; Sayag-Beaujard AC; Vignal J; Gilly FN
    Br J Surg; 2004 Jun; 91(6):747-54. PubMed ID: 15164446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and surgical treatment of gastric cancer invading adjacent organs.
    Zhang M; Zhang H; Ma Y; Zhu G; Xue Y
    ANZ J Surg; 2010; 80(7-8):510-4. PubMed ID: 20795964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis.
    Chua TC; Yan TD; Ng KM; Zhao J; Morris DL
    World J Surg; 2009 Jul; 33(7):1488-94. PubMed ID: 19412567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of peritoneal surface malignancy of colorectal cancer origin.
    Tentes AA
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s39-42. PubMed ID: 15655638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Chua TC; Morris DL; Esquivel J
    Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer.
    Steinert R; Hantschick M; Vieth M; Gastinger I; Kühnel F; Lippert H; Reymond MA
    Arch Surg; 2008 Feb; 143(2):122-8. PubMed ID: 18283136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.